CompoAtlas

AMAZOLIFE

Food supplement declared in France, declaration No 2020-8-993

AMAZOLIFE is a food supplement declared in France. Status: retiré du marché le 15 November 2025. 1 point in its composition requires a check (prohibited substance, dose or novel food). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
FIDDIAM SA
Status
Retiré du marché le 15 November 2025
Form
Gélule
Daily dose
2 gélules par jour
Directions for use
2 gélules par jour
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes, Sous anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Minceur / Modérateur d'appétit

Declaration 307489, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Malpighia glabra L.FruitExtrait sec aqueux100 mg
Lepidium meyenii Walp.RacineExtrait sec aqueux100 mg
Ptychopetalum olacoides Benth.EcorceExtrait sec aqueux100 mg
Carica papaya L.FruitPoudre (de plantes séchées ou broyées)80 mg
Passiflora edulis SimsParties aériennesExtrait sec aqueux80 mg
Paullinia cupana KunthGraineExtrait sec hydroalcoolique75 mg
Hebanthe eriantha (Poir.) PedersenRacineExtrait sec hydroalcoolique60 mg
Handroanthus impetiginosus (Mart. ex DC.) MattosEcorceExtrait sec hydroalcoolique60 mg
Euterpe oleracea Mart.FruitExtrait sec aqueux0.5 mg

Other active ingredients

NamePer day
Bromélaïnenot declared

Additives

E464, E470b, E551

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line